Genmab is an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.

Full Year 2017 Financial Results

Genmab published its full year 2017 financial results and held an investor conference call on February 21. Click  here to listen to a replay of the webcast, here to access an online overview of the Annual Report, here to view a Danish summary of the Annual Report, here to download the presentation slides and here to download an MP3 of the webcast.  

2018 Annual General Meeting

Genmab's Annual General Meeting will be held on Tuesday, April 10, 2018 at 2 PM CEST in Copenhagen, Denmark. Please click here for more information in Danish or English.  


Career Opportunities at Genmab

Genmab is seeking new employees to join our team. Visit our Careers webpages to explore current vacancies, learn about our culture and meet some of our team members